1.1 Potentials & Risks

You know that slip of paper tucked inside every medicine box? The one you likely toss aside without a glance? It may seem dull, but this little paper is a quiet triumph of the last century. That leaflet spells out four essentials: what the medicine treats, how much to take, the surprises it might bring, and who should steer clear.

Behind every line on that leaflet stands a whole machinery: clinical trials, regulators, and a responsibility to reveal mistakes. No one believes the leaflet itself heals you. Its real power is making the medicine safe for anyone. That is the magic we are missing when we let AI teach without guidance.

The AI tools now quietly settling into your school arrived with no instructions. In the UK, a review found that only 7 out of 100 education technology companies had ever put their products through a controlled trial, and only 12 out of 100 had sought outside certification. The classroom tells the same story. Only 11 out of 100 school leaders and teachers across 17 American states had ever requested peer-reviewed proof before adopting a new tool.

The result, in many cases, is wasted money. In the US, two-thirds of school software licenses gathered dust, and 98% saw almost no use. The EdTech Genome Project looked at about 7,000 teaching tools worth 13 billion dollars and found that 85% were either mismatched or misused.

This chapter may look like the dry, necessary section, but it reveals the hidden stories behind the rules. It tells what really happened, who was affected, and shines a light on the side effects, even those that quietly reached children who never signed up.